Best Fierce Life Sciences Podcasts (2024)

1
Breaking down BIOSECURE—Industry implications and what comes next 20:02

5d ago20:02

20:02

Since the introduction of the BIOSECURE Act in January, named companies and U.S.-based biopharmas alike have speculated on what the legislation could mean for the life sciences industry. In this week's episode of "The Top Line," Fierce Pharma staff writer Fraiser Kansteiner sits down with Arnold & Porter’s Life Sciences practice chair Dan Kracov to…

1
Kiki Wooten’s Breast Cancer Journey: Beautiful Strength in Being Flat-Chested, Healing the Past and Embracing the Future 50:56

5d ago50:56

50:56

In compelling episode 38 of Everything Cancer, we meet Kiana—Kiki—Wooten, a breast cancer survivor who went from stoic and shy to modeling as a vibrant flat-chested breast cancer survivor. Diagnosed at just 34 years old, Kiki’s journey through invasive ductal carcinoma was filled with life-altering challenges—sepsis, difficult reconstruction choice…

1
About Face: Terry Healey’s Transformative Journey of Determination and Purpose After Head and Neck Cancer 40:28

8d ago40:28

40:28

Welcome to Everything Cancer! In this episode, we’re joined by Terry Healey, a Head and Neck cancer survivor, public speaker, and bestselling author whose journey is nothing short of inspiring. At just 21, Terry faced a rare and life-changing cancer that affected his appearance, leading him to retreat from the world. Eventually tired of hiding, Ter…

1
ESMO, WCLC lung cancer data spark hope—and debate 23:17

12d ago23:17

23:17

At the recent World Conference on Lung Cancer and European Society for Medical Oncology annual meetings, two packages of lung cancer data from a partnership between Akeso and Summit Therapeutics and another collaboration between iTeos Therapeutics and GSK showed much promise of disrupting the current standard of care. But they also drew some questi…

1
A Different Approach to Dermatology Care 14:52

16d ago14:52

14:52

Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses how is they're positioning to capitalize on the unmet needs in other specific therapeutic areas, their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.By Pharmaceutical Executive Podcast

1
Recapping Digital Pharma East 2024 8:23

19d ago8:23

8:23

In this week's episode of "The Top Line," we’re recapping and discussing the major trends from Digitial Pharma East, which took place in Philadelphia last week. The event brought together marketing experts from across the life sciences industry. Fierce Pharma Marketing's Andrea Park and Ben Adams talk about major trends from the event that came up …

1
Solutions to Disparity in Lung Cancer Care: 2nd Lung Cancer Health Equity Summit with Dr. Eugene Manley, PhD 37:03

20d ago37:03

37:03

Dr. Eugene Manley, PhD, through his SCHEQ (STEMM Cancer Health Equity) Foundation, is dedicated to addressing disparities in lung cancer research, screening, lung cancer care for underserved communities and patients, and STEMM careers. In the 36th episode of the Everything Cancer Podcast, Dr. Eugene Manley, PhD, joins us to discuss the important wo…

1
A closer look at the Fierce 50 7:24

26d ago7:24

7:24

In this week's episode of "The Top Line," we will dive into the annual Fierce 50 special report. We share the stories of a select few 2024 Fierce 50 honorees and interesting highlights from this year's special report. To learn more about the topics in this episode: Fierce 50 of 2024 Innovation Honorees Health Equity Honorees Social Impact Honorees …

1
Rochelle Prosser: Fierce Mom of a Pediatric Cancer Survivor, Champion of Patient Rights in Healthcare Legislation, Explainer of Cancer X Moonshot, and Navigator Extraordinaire 53:59

28d ago53:59

53:59

Welcome to Everything Cancer! Today, we’re joined by Rochelle Prosser, a powerhouse in patient advocacy and cancer navigation who’s making waves in cancer survivorship: She is the founder of Orchid Health Solutions and Prosser Cancer Library, dedicated to innovation, dignity, and the dismantling of disparity in cancer care delivery. We find part of…

1
A look at flu vaccine manufacturing and supply in the post-pandemic era 17:10

1M ago17:10

17:10

In this week's episode of "The Top Line," we’re looking at what goes into manufacturing and supply of flu vaccines. Fierce Pharma’s Zoey Becker chats with Stefan Merlo, vice president of commercial operations, North America at CSL Seqirus. He discusses the company's differentiated flu vaccine portfolio and how its manufacturing process has evolved …

1
Beyond the Birthrate: The Societal Costs of Maternal Morality 15:48

1M ago15:48

15:48

In this episode of the Pharmaceutical Executive podcast, Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusses: The broader societal implications of these maternal health issues highlighted in The Commonwealth Fund study The most critical changes needed to close the gaps in R&D for maternal health solutions …

1
The Dr. Sam and Dr. Sam Siegel Method: Married Cancer Survivors Balancing Family, Medicine, Living Fully, and Innovation with an Onco-Generalist Practice 1:12:04

1M ago1:12:04

1:12:04

They keep it real, relatable, and full of passion: True Grit In this heartfelt and candid episode of Everything Cancer, we sit down with Dr. Sam Siegel, a pediatrician, and Dr. Sam Siegel, an onco-generalist doing the heavy lift of starting a survivorship practice. Both doctors are not only healthcare providers but also cancer survivors who each ex…

1
Bridging the Gap: The Vital Role of Community for Those Affected By Cancer – Meet Stephanie Ciranni, Executive Director of Cancer Bridges 39:34

1M ago39:34

39:34

In this episode of Everything Cancer, we’re joined by Stephanie Ciranni, the dynamic Executive Director of Cancer Bridges, in Pittsburgh, PA, Everything Cancer host Jill's hometown. If you’re a cancer survivor or your life has been altered by cancer, Stephanie encourages you to explore local cancer support organizations in your area and connect wit…

1
Driving flu vaccine uptake in the post-pandemic era 20:46

1M ago20:46

20:46

In this week's episode of "The Top Line," we look at factors driving the continuing decline of flu vaccination rates in the U.S. and beyond. Fierce Pharma’s Zoey Becker chats with Gregg Sylvester, M.D., Chief Health Officer at CSL Seqirus, to get insight on what we might expect to see from this upcoming flu season. He also explains efforts to incre…

1
The Crucial Role of HEK293 DNA Quantification in Biotherapeutics [Sponsored by Bio-Rad Laboratories] 13:42

2M ago13:42

13:42

Biotherapeutics are transforming healthcare for over 350 million patients globally, tackling everything from cancer and diabetes to rare diseases. Human embryonic kidney (HEK) 293 cells play a key role in the manufacturing of many of these life-changing products. However, they are not without their challenges. In this episode of The Top Line, spons…

1
What Chevron’s overturn means for biopharma 25:15

2M ago25:15

25:15

For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of agencies. This stipulation, called the Chevron deference, gave agencies room to advance their regulatory priorities. The Supreme Court overturned the doctrine in June, bringing significant implications …

1
What an Integrative Oncology Survivorship Center Looks Like: Take a podcast tour with us and their awesome manager 30:46

2M ago30:46

30:46

In episode 32 of Everything Cancer, we delve into the impactful work of Prisma Health Cancer Institute's Center for Integrative Oncology Survivorship and Center for Cancer Prevention and Wellness. Jason King, Assistant Manager at the Center, takes us on a tour, explaining how they’ve expanded over the past 11 years with the growing recognition of t…

1
The TROP2 race for supremacy 24:41

2M ago24:41

24:41

The TROP2 antibody-drug conjugate race has heated up among three Big Pharma companies: Gilead Sciences, AstraZeneca and Merck. Fierce Pharma’s Angus Liu recently took a deep dive into the three TROP2 front-runners. In a feature article, he examined the strengths and potential challenges facing each candidate, as well as the considerations behind th…

1
Unbreakable Spirit: Host of YouTube's 2BeYourOwnHero, Mark Kagayama's Story of Hope, Healing, and Quiet Determination in the Face of Stage IV Cancer 46:20

2M ago46:20

46:20

In episode 31 of Everything Cancer, we sit down with the gracious and perseverant Mark Kagayama, inspiring host of the YouTube channel 2BYourOwnHero. Mark shares his incredible journey from being a health-conscious vegan to facing a life-altering diagnosis of stage IV cancer. He takes us on his odyssey with him, with his genuine and unique style of…

1
Season 2 Trailer: Coming Fall 2024 1:43

2M ago1:43

1:43

1
NCCS: National Coalition for Cancer Survivorship - Championing Survivors to Infinity and Beyond: An Interview with Dr. Veronika Panagiotou, PhD 58:34

2M ago58:34

58:34

What really happens behind the scenes in the world of national policy and legislative cancer survivorship advocacy? Dr. Panagiotou pulls back the curtain and takes us on an enlightening tour of NCCS’s mission, shedding light on how they’re ensuring the voices of survivors shape the future of cancer care at the highest levels. She keeps the conversa…

1
A closer look at Fierce Biotech's Fierce 15 11:17

2M ago11:17

11:17

In this week's episode of "The Top Line," we’re diving into Fierce Biotech’s annual Fierce 15 special report. Fierce Biotech's Annalee Armstrong and Gabrielle Masson take you behind the scenes to explore the meticulous selection process and share interesting highlights from this year’s honorees. To learn more about the topics in this episode: Intro…

1
Empty Shelves, Urgent Solutions 18:39

2M ago18:39

18:39

Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts and the main factors that are contributing to the closures of both large and independent pharmacies, what alternative solutions can help ensure continued access to medications for all Americans (particularly those in underserved communities), some potential long ter…

1
What 'The Next Berlin Patient' and a PrEP’s 100% efficacy mean for HIV drug development 26:38

2M ago26:38

26:38

This week on “The Top Line,” we discuss two studies in HIV research that were presented at the 25th International AIDS Conference in Germany. One of them is the report of a 7th person who has likely been cured of HIV. And there’s something unique about this case that has sparked excitement among scientists. The other one is the report of a long-act…

1
Kintzugi—Finding Beauty in Brokenness: An Interview with Grief Therapist and Cancer Survivor, Harriet Cabelly 41:56

2M ago41:56

41:56

Join us on this episode of Everything Cancer as we welcome the insightful and genuine Harriet Cabelly, a grief therapist, positive psychology coach, cancer thriver, speaker, and author. Harriet shares her profound journey from being a school social worker to her true calling in grief therapy. She candidly discusses her own experiences with grief, f…

1
Fierce 15: Where are they now? 10:02

3M ago10:02

10:02

In this week’s episode of "The Top Line," Fierce Biotech’s Annalee Armstrong highlights some of the most promising companies that made our prestigious Fierce 15 list back in 2014. A decade later, she revisits these trailblazers to see how they’ve navigated the biotech landscape. To learn more about the topics in this episode: Fierce Biotech's Fierc…

1
Lubricants 101: The Essential Guide to Lubricants for Cancer Survivors 17:13

3M ago17:13

17:13

In this episode, we explore the benefits of lubricants for cancer survivors, focusing on how lubricants can enhance sexual pleasure, make penetration easier with decreased penile firmness, relieve vaginal dryness, reduce pain during penetration, and decrease performance anxiety. Avoid lubricants containing irritants such as chlorhexidine gluconate …

1
Former FTC director weighs in on Novo's $16.5B deal with Catalent 17:18

3M ago17:18

17:18

Back in February, Novo Holdings laid out a $16.5 billion deal to snap up contract manufacturing giant Catalent. In this week's episode of "The Top Line," we dive into the current state and implications of the proposed buyout. Fierce Pharma’s Fraiser Kansteiner is joined by former FTC policy director David Balto. They discuss the likelihood of the d…

1
Are You Curious About Integrative Health and Oncology Nutrition Counseling? Join us for a conversation with a retired surgical breast oncologist turned Certified Oncology Nutrition Counselor and Integrative ... 44:50

3M ago44:50

44:50

Dr. Cynthia Aks, retired integrative breast surgical oncologist, certified yoga therapist, energy healer, integrative health coach, and oncology nutrition counselor, joins us. Dr. Aks shares her extensive knowledge of integrative health. Cynthia discusses how nutritional values in food impact our well-being. She explains the importance of individua…

1
Find out what to expect from the PDA/FDA Joint Regulatory Conference (Sponsored by Parenteral Drug Association) 13:45

3M ago13:45

13:45

In this episode of The Top Line, sponsored by the Parenteral Drug Association (PDA), we explore the upcoming PDA/FDA Joint Regulatory Conference, happening September 9-11 in Washington, D.C. Our guest, Janeen Skutnik-Wilkinson, Director of Global Quality Regulatory Surveillance and External Engagement for Moderna and Co-Chair of the 33rd annual eve…

1
A look at Big Pharma’s top-paid CEOs 10:47

3M ago10:47

10:47

Pharmaceutical CEOs often earn pay packages worth tens of millions of dollars for leading the top drugmaking companies in the industry. Every year, some new faces enter the rankings while others leave. In this week's episode of "The Top Line," Fierce Pharma’s Eric Sagonowsky and Fraiser Kansteiner discuss Fierce’s annual special report, “Big Pharma…

51
The Weight-Loss Gold Rush: Legal and Regulatory Implications 17:10

3M ago17:10

17:10

Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses: Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs What needs to be done…

1
From the Depths of Despair to Embracing Life: The Stage IV Colon Cancer Survivor Journey of Dr. Jonathan Raviotta PhD, Public Health 1:01:15

3M ago1:01:15

1:01:15

Welcome to Everything Cancer! In today's episode, we sit down with Dr. Jonathan Raviotta, PhD in Public Health and Associate Professor at the University of Pittsburgh. Jonathan shares his remarkable four-year journey through cancer and personal transformation. His story is a testament to resilience and the power of human connection. Jonathan’s trea…

1
Spa Day for Your Mouth (say good-bye to dry mouth!) - Dr. Rajiv Saini, Chief Science Officer of H2Ocean, joins us to discuss the benefits of Red Sea Salt 35:53

3M ago35:53

35:53

🦷 Do you experience dry mouth or that awful metallic taste? Want to know a great way to soothe mouth sores and help them heal quickly? Dr. Rajiv Saini has your answer! Welcome to the "Everything Cancer" podcast. Today, we're delving into the vital topic of mouth care with Dr. Rajiv Saini, Chief Science Officer at H2Ocean. Dr. Saini discusses why go…

1
The best biopharma M&A deals 15:02

3M ago15:02

15:02

At Fierce Biotech, we love a big M&A deal, but valuation does not always equal the most exciting. In this week's episode of "The Top Line," Fierce Biotech’s Annalee Armstrong and James Waldron discuss what they think are the best and smartest acquisitions in recent years. From obesity to radiopharmaceuticals, they give you the Fierce Biotech team’s…

1
Survivor Guilt is a Thing... and it became former CIA team member Ellen’s drive to advocate for others 44:29

4M ago44:29

44:29

Self-described mom, wife, cyclist, and plant-killer, Ellen Goodwin’s fascinating journey from the CIA to cancer advocacy will inspire. Ellen talks with Jill about how she grapples with survivor's guilt but has found purpose in advocating for breast cancer research through Komen. She shares with the audience how much the community and support of her…

1
A closer look at 'friend-shoring' and the drug shortage challenge 17:54

4M ago17:54

17:54

In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing. "Friend-shoring" involves conducting manufacturing processes in countries considered friendly or allied. Sheng discusses the criteria for deeming a count…

1
Cancer is an A$$hole: Interview with Amanda Ferarro - Leukemia Survivor, Patient Advocate, TEDxSpeaker 55:32

4M ago55:32

55:32

Meet Amanda Ferarro: Dive into Amanda's powerful journey as a cancer survivor, healthcare influencer, and bestselling author. Amanda tells it like it is and pulls no punches! Yet she offers real hope, humor, authenticity, and advocacy. TEDx Speaker: Hear about Amanda's impactful TEDx talk, sharing her story and advocating for cancer survivors: Thro…

1
Inside this year’s ASCO: Biggest data drops, trends and the best exhibit booth 13:35

4M ago13:35

13:35

Each June, the American Society of Clinical Oncology (ASCO) hosts a conference that gathers physicians, researchers and the cancer community to share their latest research on treatments, technologies and more. The Fierce team is always on the ground at the ASCO meeting, and this year, Fierce Biotech’s Gabrielle Masson and Fierce Pharma’s Angus Liu …

1
"Showing Up: Perspectives on Cancer" Host Tim Sohn talks about why it is so important that survivors know they are not alone 51:23

4M ago51:23

51:23

Tim Sohn, a CML cancer survivor, hosts and produces the weekly live-stream show, “Showing Up: Perspectives on Cancer”. Tim and his survivor guests prove how valuable the shared experience can be. Jill and Tim discuss the challenges of engaging in life with an “invisible illness”. Today, Tim joins the podcast and shows us his gift of making us feel …

1
A look at the top 10 pharma drug ad spenders 9:35

4M ago9:35

9:35

The Fierce Pharma Marketing team publishes a special report each year on the top pharmaceutical drug ad spenders. This year’s report, which includes numbers for 2023, was published on Monday. AbbVie was the standout in this edition, having spent heavily on ads for Skyrizi and Rinvoq. Overall spending on the top 10 ads also experienced a sizable inc…

1
A Clinical Oncology Pharmacist Has Your Back: discover their superpowers in this episode 52:20

4M ago52:20

52:20

A clinical oncology pharmacist has your back! They can help ensure you understand your treatment and how to manage its side effects. They are experts in how your treatment interacts with other medications and supplements you take. In this episode of Everything Cancer, we dive into the pivotal role of a clinical oncology pharmacist with our guest, M…

1
How Sunstone Therapies is Opening Doors to Psychedelic Treatment 46:49

4M ago46:49

46:49

In this episode I speak to Norma Stevens, LCPC, the Director of Therapy Operations at Sunstone Therapies in Rockville, Maryland. Sunstone partners with companies like Beckley PsyTech, COMPASS Pathways, MindMed, MAPS (Lykos Theraputics), Reunion Neuroscience, and Usona to run studies that aim to establish the gold standard for psychedelic treatments…

1
A cell therapy reckoning 6:31

4M ago6:31

6:31

The Fierce Biotech team published a four-part series this week exploring cell therapy, a modality that has faced clinical challenges, manufacturing constraints and multiple practice-changing events. In today’s episode, Fierce’s Annalee Armstrong and Gabrielle Masson discuss the series of special reports and key insights from their interviews with m…

1
Fierce Advocacy for Those Who Live with Lymphedema: A woman’s 13-year battle to get the Lymphedema Treatment Act passed in the US 42:55

5M ago42:55

42:55

Heather worked relentlessly to improve accessibility to and coverage of Lymphedema Treatment vastly! In this compelling episode of Everything Cancer, we sit down with Heather Ferguson, founder and executive director of the Lymphedema Advocacy Group, recently known as Lymphedema Treatment Act.org. Find out how Heather’s 13-year odyssey at the level …

1
Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing (Part III) 39:37

5M ago39:37

39:37

This week’s episode of “The Top Line,” is the final part of a three-part series diving into the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s Fraiser Kansteiner is joined by Bruce Levine, Ph.D., who is the co-inventor of Kymriah and the Barbara and Edward Netter Professor in Cancer Gene Therapy at the …

1
Part 2, Dr. Alique Topalian, PhD: Legislative and Academic Warrior for All Cancer Survivors, Pediatric and AYA Cancer Survivor and Thriver 37:12

5M ago37:12

37:12

Episode Description: In the second part of our interview with Dr. Alique Topalian, PhD in Health Promotion Education, we continue to explore her remarkable journey as both a pediatric and young adult cancer survivor. Dr. Topalian delves deeper into her advocacy work, fighting for legislative changes to support all cancer survivors. Dr. Topalian is …

1
[Sponsored] Opportunities & Challenges of Digital Pathology Adoption in CDx Development 17:00

5M ago17:00

17:00

In the fast-paced field of life sciences, digital pathology is poised to be a game-changer. In this episode, we sit down with Grace Lee and Douglas Clark of Agilent Technologies to explore the opportunities and challenges associated with companion diagnostics (CDx). Clark kicks off, shedding light on the current levels of digital pathology adoption…

1
Part 1 - Dr. Alique Topalian, PhD, MPH: Legislative and Academic Warrior for All Cancer Survivors, Pediatric and AYA Cancer Survivor and Thriver 38:50

5M ago38:50

38:50

Episode Description: In this first part of our interview with Dr. Alique Topalian, we explore her incredible journey as both a pediatric and young adult cancer survivor. Dr. Topalian shares her experiences with self-advocacy, the challenges of finding a bone marrow match, and her involvement in bio-marker insurance coverage legislation. She discuss…

1
“Chemo Brain” is for Real, and There is Real Help - A Discussion on Chemotherapy-Induced Cognitive Impairment 38:02

5M ago38:02

38:02

Today, Jill is joined by Doreen Bridgman and Marilyn Abrahamson, the brilliant and compassionate minds behind Brain Thrive—Brain Health Coaching. These experienced speech-language pathologists dive into the realities of "Chemo Brain," a common yet often misunderstood side effect of chemotherapy. If you find mind fatigue, fogginess, and forgetfulnes…

Podcasts Worth a Listen

Fierce Life Sciences Podcasts

Podcasts Worth a Listen

Quick Reference Guide